Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

11 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Autoantibodies to cyclic citrullinated peptide 2 (CCP2) are superior to other potential diagnostic biomarkers for predicting rheumatoid arthritis in early undifferentiated arthritis.
Kudo-Tanaka E, Ohshima S, Ishii M, Mima T, Matsushita M, Azuma N, Harada Y, Katada Y, Ikeue H, Umeshita-Sasai M, Miyatake K, Saeki Y. Kudo-Tanaka E, et al. Clin Rheumatol. 2007 Oct;26(10):1627-33. doi: 10.1007/s10067-007-0558-5. Epub 2007 Feb 8. Clin Rheumatol. 2007. PMID: 17286215
Baseline anti-citrullinated peptide antibody (ACPA) titers and serum interleukin-6 (IL-6) levels possibly predict progression of bone destruction in early stages of rheumatoid arthritis (ERA).
Saeki Y, Kudo-Tanaka E, Ohshima S, Matsushita M, Tsuji S, Maeda Y, Yoshimura M, Watanabe A, Katada Y, Harada Y, Ichikawa K, Suenaga Y, Ohta Y, Tohma S; NHO iR-net Study Group. Saeki Y, et al. Among authors: kudo tanaka e. Rheumatol Int. 2013 Feb;33(2):451-6. doi: 10.1007/s00296-012-2397-1. Epub 2012 Mar 29. Rheumatol Int. 2013. PMID: 22457007
Early therapeutic intervention with methotrexate prevents the development of rheumatoid arthritis in patients with recent-onset undifferentiated arthritis: A prospective cohort study.
Kudo-Tanaka E, Shimizu T, Nii T, Teshigawara S, Yoshimura M, Watanabe A, Tsuji S, Tsuboi H, Hirao M, Yura A, Harada Y, Sueishi M, Suenaga Y, Chiba N, Tonai T, Saisho K, Ogata A, Matsushita M, Hashimoto J, Ohshima S, Tohma S, Saeki Y. Kudo-Tanaka E, et al. Mod Rheumatol. 2015;25(6):831-6. doi: 10.3109/14397595.2015.1031364. Epub 2015 Apr 30. Mod Rheumatol. 2015. PMID: 25800638
Hemophagocytic lymphohistiocytosis with leukoencephalopathy in a patient with dermatomyositis accompanied with peripheral T-cell lymphoma: a case report.
Teshigawara S, Katada Y, Maeda Y, Yoshimura M, Kudo-Tanaka E, Tsuji S, Harada Y, Matsushita M, Ohshima S, Watanabe K, Kumode T, Hoshida Y, Saeki Y. Teshigawara S, et al. Among authors: kudo tanaka e. J Med Case Rep. 2016 Aug 2;10:212. doi: 10.1186/s13256-016-0986-4. J Med Case Rep. 2016. PMID: 27484255 Free PMC article.
Sporotrichal Tenosynovitis Diagnosed Helpfully by Musculoskeletal Ultrasonography.
Shimizu T, Akita S, Harada Y, Oguro E, Okita Y, Shigesaka M, Matsuoka H, Nii T, Teshigawara S, Kudo-Tanaka E, Tsuji S, Matsushita M, Ohshima S, Hoshida Y, Hashimoto J, Saeki Y. Shimizu T, et al. Among authors: kudo tanaka e. Intern Med. 2017;56(10):1243-1246. doi: 10.2169/internalmedicine.56.7912. Epub 2017 May 15. Intern Med. 2017. PMID: 28502945 Free PMC article.
Crosstalk between tumor necrosis factor-alpha signaling and aryl hydrocarbon receptor signaling in nuclear factor -kappa B activation: A possible molecular mechanism underlying the reduced efficacy of TNF-inhibitors in rheumatoid arthritis by smoking.
Nii T, Kuzuya K, Kabata D, Matsui T, Murata A, Ohya T, Matsuoka H, Shimizu T, Oguro E, Okita Y, Udagawa C, Yoshimura M, Kudo-Tanaka E, Teshigawara S, Harada Y, Yoshida Y, Isoda K, Tsuji SI, Ohshima S, Hashimoto J, Shintani A, Takehana Y, Tohma S, Saeki Y. Nii T, et al. Among authors: kudo tanaka e. J Autoimmun. 2019 Mar;98:95-102. doi: 10.1016/j.jaut.2018.12.004. Epub 2018 Dec 25. J Autoimmun. 2019. PMID: 30591403
11 results